Private Market Investing
Designed for private market investors, Cority's market-leading solutions empower responsible investment decisions at every step of the ESG journey.
The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.
These efforts are driven by the need for transparency, compliance, and sustainability in response to pressures from stakeholders, including investors, regulators, and consumers. In this piece, industry experts share their insights on the actions being taken and the challenges faced in this important area.
Sign up for EHS and ESG news and best practices. Get notified on upcoming webinars, exclusive events, and industry news.
CEO
Mark is CEO of Cority Software Inc., a Toronto-based, award-winning, global SaaS company. Under Mark’s leadership, Cority’s revenue has grown consistently at a compounded rate of 25%. The company has grown in employees from 29 when Mark started in 2003 to close to 400 employees today. It enjoys an industry-leading profit margin. In 2016, Cority raised capital with Norwest Venture Partners, Georgian Partners, and BMO; in 2019 Cority raised capital from software specialist Private Equity firm Thoma Bravo and with Norwest again stepping up as an investor. Mark was a finalist for the EY Entrepreneur of the Year Award in 2017 and 2018. Previously, Mark was Vice President, General Counsel & Corporate Secretary and a member of the executive management team of AT&T Canada Corp. Mark is a graduate of St. Francis Xavier University, where he recently completed 10 years on the Board of Governors, including four as Chair of the Board. He received his J.D. from the University of Victoria and is a member of the Law Society of Upper Canada. Mark is active in mentoring young entrepreneurs and has served on several other not for profit boards.
